Green Cross Corporation
CompanySouth Korea
Green Cross Corporation develops one asset, in phase 2 (Varicella Vaccine). Mostly vaccine; based in South Korea.
- 1
- Asset
- Furthest stage
- Phase 2
- 3
- Trials
- 3
- Signals
Pipeline
1Induces protective immunity against varicella-zoster virus.
Phase 2, Vaccine
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials4
- Signals19
- Integrity notices1